Sanofi Vaccine Covid Us. If the data are positive, the companies can request u.s. The company is expected to release the results from the phase i/ii clinical trials this month.
The company is expected to release the results from the phase i/ii clinical trials this month. Sanofi is pursuing two vaccine candidates. The one that’s being funded by barda builds on past development work involving the sars epidemic and technology it already employs in one of.
Regulatory approval in the first half of 2021.
The trial will enroll 440 healthy adults in the us to evaluate the vaccine’s safety, tolerability and immune response. The company is expected to release the results from the phase i/ii clinical trials this month. It is also developing a vaccine with u.s. The trial will enroll 440 healthy adults in the us to evaluate the vaccine’s safety, tolerability and immune response.
